Senti Biosciences (SNTI) Stock: Buy, Sell, or Hold?
SNTI - Senti Biosciences, Inc. Common Stock
$0.31
0.00 (-0.10%)
▼
5d:
-1.87%
30d:
-17.85%
90d:
-71.85%
HOLD
LOW Confidence
Analysis Updated: Sep 29, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When SNTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNTI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SNTI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SNTI is currently trading at $0.31, which is considered fair relative to its 30-day fair value range of $0.31 to $0.40.
Technical Outlook: Technically, SNTI is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.37.
Market Sentiment: SNTI scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.50 (+4254.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNTI is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.37.
Market Sentiment: SNTI scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.50 (+4254.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.31 -
$0.40
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (73/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4254.8% below Wall St target ($13.50)
- CAUTION: Bottoming setup, but lagging the sector by 30% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.31 -
$0.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.29
Resistance Level
$0.37
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.33
Wall Street Target
$13.50
(+4254.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 29, 2026 11:31 AM ET
Data refreshes hourly during market hours. Next update: 12:31 PM
Data refreshes hourly during market hours. Next update: 12:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 71 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 58 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 54 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$103 | 56 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$107 | 61 BUY |
